Article

Serono, Inc. Names Paul Lammers Chief Medical Officer

Serono, Inc. (Rockland, MA, www.serono.com) has named Paul Lammers, MD, as its US Chief Medical Officer.

Serono, Inc. (Rockland, MA, www.serono.com) has named Paul Lammers, MD, as its US Chief Medical Officer. In his new role, Lammers will be responsible for overseeing clinical development, including product safety and medical information, and for managing the medical affairs and regulatory affairs functions. The company also named James Hoyes to the role of US Chief Commercial Officer.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
How the 15% US-EU Tariff Cap Affects Bio/pharma
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
© 2025 MJH Life Sciences

All rights reserved.